Evidence map›Paper›PMID 34952885›Full record

Observational studyBMJ open2021

Assessing the impact of simplified HCV care on linkage to care amongst high-risk patients at primary healthcare clinics in Malaysia: a prospective observational study.

Jessica Markby, Sonjelle Shilton, Xiaohui Sem, Huan Keat Chan, Rosaida Md Said, Sasikala Siva, Zalwani Zainuddin, Norasiah Abu Bakar, Haniza Omar, Ryan Jose Iii Ruiz and 17 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Acceptability and Effectiveness of Point-of-Care HCV Testing in Low- and Middle-Income Countries: A Systematic Review.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Knowledge, Attitude and Factors associated with Self-efficacy in Screening and Treatment of Hepatitis C among Primary Care Doctors in Selangor.Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 13 institutions in 5 countries.

Jessica MarkbyFIND, Geneva, Switzerland.
Sonjelle ShiltonFIND, Geneva, Switzerland sonjelle.shilton@finddx.org.ORCID 0000-0003-1569-8758
Xiaohui SemFIND, Geneva, Switzerland.
Huan Keat ChanClinical Research Centre, Hospital Sultanah Bahiyah, Alor Setar, Malaysia.
Rosaida Md SaidHospital Ampang, Ampang Jaya, Malaysia.
Sasikala SivaDrugs for Neglected Diseases initiative, Geneva, Switzerland.
Zalwani ZainuddinHospital Sultanah Bahiyah, Alor Setar, Malaysia.
Norasiah Abu BakarHospital Raja Perempuan Zainab II, Kota Bharu, Malaysia.
Haniza OmarHospital Selayang, Batu Caves, Malaysia.
Ryan Jose Iii RuizFIND, Geneva, Switzerland.
Mary GaeddertDivision of Clinical Tropical Medicine, Center of Infectious Diseases, University Hospital Heidelberg, Heidelberg, Germany.
Alexander TyshkovskiyDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Madeline AdeeInstitute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Jagpreet ChhatwalInstitute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0001-8741-4430
Suresh KumarHospital Sungai Buloh, Sungai Buloh, Malaysia.
Jean-Michel PiedagnelDrugs for Neglected Diseases initiative, Geneva, Switzerland.
Rozainanee Mohd ZainInstitute for Medical Research, Kuala Lumpur, Malaysia.
Caroline MenétreyDrugs for Neglected Diseases initiative, Geneva, Switzerland.
Fazidah YuswanDisease Control Division, Ministry of Health, Putrajaya, Malaysia.
Nazrila Hairizan NasirFamily Health Development Division, Ministry of Health, Putrajaya, Malaysia.
Isabelle Andrieux-MeyerDrugs for Neglected Diseases initiative, Geneva, Switzerland.
Fatanah IsmailFamily Health Development Division, Ministry of Health, Putrajaya, Malaysia.
Rozita ZakariaFamily Health Development Division, Ministry of Health, Putrajaya, Malaysia.
Ruziaton HasimFamily Health Development Division, Ministry of Health, Putrajaya, Malaysia.
Shahnaz MuradDrugs for Neglected Diseases initiative, Geneva, Switzerland.
Philippa EasterbrookGlobal HIV, Hepatitis & STI Programmes, World Health Organization, Geneva, Switzerland.
Muhammad Radzi Abu HassanClinical Research Centre, Hospital Sultanah Bahiyah, Alor Setar, Malaysia.
Drugs for Neglected Diseases Initiative · CHMinistry of Health · MYFIND · CHHospital Sultanah Bahiyah · MYHarvard University · USBrigham and Women's Hospital · USHeidelberg University · DEHospital Raja Perempuan Zainab II · MYHospital Selayang · MYHospital Sungai Buloh · MYInstitute for Medical Research · MYKPJ Ampang Puteri Specialist Hospital · MYWorld Health Organization · CH

Funding

AHRQ HHS T32 HS022241World Health Organization 001
6 · The paper itself

Abstract

introductionTo achieve the elimination of hepatitis C virus (HCV), substantial scale-up in access to testing and treatment is needed. This will require innovation and simplification of the care pathway, through decentralisation of testing and treatment to primary care settings and task-shifting to non-specialists. The objective of this study was to evaluate the feasibility and effectiveness of decentralisation of HCV testing and treatment using rapid diagnostic tests (RDTs) in primary healthcare clinics (PHCs) among high-risk populations, with referral of seropositive patients for confirmatory viral load testing and treatment.

methodsThis observational study was conducted between December 2018 and October 2019 at 25 PHCs in three regions in Malaysia. Each PHC was linked to one or more hospitals, for referral of seropositive participants for confirmatory testing and pretreatment evaluation. Treatment was provided in PHCs for non-cirrhotic patients and at hospitals for cirrhotic patients.

resultsDuring the study period, a total of 15 366 adults were screened at the 25 PHCs, using RDTs for HCV antibodies. Of the 2020 (13.2%) HCV antibody-positive participants, 1481/2020 (73.3%) had a confirmatory viral load test, 1241/1481 (83.8%) were HCV RNA-positive, 991/1241 (79.9%) completed pretreatment assessment, 632/991 (63.8%) initiated treatment, 518/632 (82.0%) completed treatment, 352/518 (68.0%) were eligible for a sustained virological response (SVR) cure assessment, 209/352 (59.4%) had an SVR cure assessment, and SVR was achieved in 202/209 (96.7%) patients. A significantly higher proportion of patients referred to PHCs initiated treatment compared with those who had treatment initiated at hospitals (71.0% vs 48.8%, p<0.001).

conclusionsThis study demonstrated the effectiveness and feasibility of a simplified decentralised HCV testing and treatment model in primary healthcare settings, targeting high-risk groups in Malaysia. There were good outcomes across most steps of the cascade of care when treatment was provided at PHCs compared with hospitals.

Indexed as

HepacivirusHepatitis CAdultAntiviral AgentsHumansMalaysiaPrimary Health CareAntiviral Agentshepatologyprimary carepublic health

Identifiers

PMID34952885
PMCPMC8713014
OpenAlexW4200317990

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.